Anti-Human PCSK9 Recombinant Antibody(Bococizumab)

Name: Anti-Human PCSK9 Recombinant Antibody(Bococizumab)
Brand: KMD Bioscience
SKU: YR1327

YR1327

科研级 Bococizumab ( 伯考赛珠单抗 ), Anti-PCSK9 Recombinant Antibody, Research Grade Bococizumab

DATASHEET MSDS

Product Description

Alias	科研级 Bococizumab ( 伯考赛珠单抗 ), Anti-PCSK9 Recombinant Antibody, Research Grade Bococizumab
Catalog Number	YR1327
Molecular Name	Bococizumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG2 Kappa
Formulation	PBS, pH7.5
Background	Bococizumab (USAN, development code RN316) is a drug that was in development by Pfizer targeting PCSK9 to reduce LDL cholesterol. Pfizer withdrew the drug from development in November 2016, determining that it was "not likely to provide value to patients, physicians or shareholders."
CAS Number	1407495-02-6
Application	FCM, IP, ELISA, Neut, FuncS
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	PCSK9[Homo sapiens]

Login